Kyntra Bio (KYNB) Earnings Analysis

Kyntra Bio (KYNB) next reports earnings on 2026-08-10, consensus EPS -3.18 USD. Last quarter (2026-05-11) it missed with EPS -3.74 USD vs -3.36 USD est (-11.3%). It has beaten estimates in 3/6 recent quarters (50%). Trailing P/E 0.17.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does KYNB next report earnings?

Next earnings date2026-08-10
Consensus EPS estimate-3.18 USD
Revenue estimate0.00B

KYNB earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-11-3.74 USD-3.36 USD-11.3%Miss
2026-03-16-3.61 USD-3.89 USD+7.2%Beat
2025-11-10-1.61 USD-4.01 USD+59.9%Beat
2025-08-11-3.38 USD-2.25 USD-50.2%Miss
2025-05-12-4 USD0.75 USD-633.3%Miss
2025-03-17-0.08 USD-0.08 USD0%Beat

Beat rate: 3/6 (50%) over reported quarters with consensus data.

KYNB valuation and analyst view

Trailing P/E0.17
Trailing EPS40.429 USD
Price / book-0.67
Dividend yield0.00%
Market cap0.03B
Analyst consensusHold (5 buy / 8 hold / 2 sell)

Related research pages

Frequently asked questions

When is Kyntra Bio (KYNB)'s next earnings date?

Kyntra Bio is next scheduled to report on 2026-08-10, with a consensus EPS estimate of -3.18 USD and revenue estimate of 0.00B.

Did KYNB beat earnings last quarter?

In its 2026-05-11 report, KYNB posted EPS of -3.74 USD versus a -3.36 USD estimate — a miss of 11.3%.

What is KYNB's earnings track record?

Over the last 6 reported quarters with consensus data, KYNB beat estimates 3 times (50%).

What is KYNB's current P/E ratio and EPS?

KYNB trades at a trailing P/E of 0.17 on trailing EPS of 40.428712626637015 USD.

What do analysts rate KYNB?

Analyst consensus is "Hold" across 15 ratings (0 strong buy, 5 buy, 8 hold, 2 sell, 0 strong sell).